It's the first time the Europeans have cleared a COVID-19 vaccine for use in young children. Plus, the latest stats and your guide to staying safe this holiday season.
THE HAGUE, Netherlands (AP) — The European Union's drug regulator on Thursday authorized Pfizer’s coronavirus vaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils amid a new wave of infections sweeping across the continent.
The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise.
For the first time, 100,000 Americans died of drug overdoses in one year. One reason is the growing prevalence of deadly fentanyl in the illicit drug supply.
WASHINGTON (AP) — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.
NEW YORK (AP) — An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available nationwide as early as this weekend.
LONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
WASHINGTON (AP) — President Joe Biden on Friday chose Dr. Robert Califf, a former Food and Drug Administration commissioner and prominent medical researcher, to again lead the powerful regulatory agency.
Brooke Shields didn’t take painkillers after her horror fall earlier this year, becuase she was worried she would develop a reliance on opioids.
Booster doses haven't eased the fears of some immunocompromised people.
A second man has agreed a plea deal for supplying the drugs that led to Mac Miller's fatal overdose in September 2018.
Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings.
Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine since September.
Pfizer says its experimental COVID-19 pill cut hospitalization and death by 90%, will seek authorization.
LONDON (AP) — Britain granted conditional authorization on Thursday to the first pill shown to successfully treat COVID-19 so far. It also is the first country to OK the treatment from drugmaker Merck, although it wasn't immediately clear how quickly the pill would be available.
Vaccinations finally are available to U.S. children as young as 5, to the relief of some parents even as others have questions or fears.
Anticipating a green light from vaccine advisers, the Biden administration is assembling and shipping millions of COVID-19 shots for children ages 5-11.
A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer's COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.
Millions more Americans are closer to getting a COVID-19 booster as CDC advisers on Thursday endorsed extra doses of all three of the nation's vaccines — and said people could choose a different brand for that next shot.
U.S. regulators signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccines and said anyone eligible for an extra dose can get a brand different from the one they received initially.
A panel of U.S. health advisers endorsed booster doses of Johnson & Johnson's single-shot COVID-19 vaccine Friday.
U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
(Bloomsbury: 432 pages, $28)
Napa County reported 15 people hospitalized locally with coronavirus as of Wednesday, with 21% of intensive care beds available.
President Joe Biden received his COVID-19 booster shot on Monday, days after federal regulators recommended a third dose of the Pfizer vaccine for Americans age 65 or older.